506 results on '"Reichert, Janice M."'
Search Results
2. Antibody–drug conjugates come of age in oncology
3. Antibodies to watch in 2024
4. Bispecific antibodies: a mechanistic review of the pipeline
5. Evolution of Antibody Therapeutics
6. Antibodies to watch in 2023
7. Future directions for peptide therapeutics development
8. The future of antibodies as cancer drugs
9. Antibodies to watch in 2023.
10. Abciximab (Reopro®), Bevacizumab (Avastin®), Certolizumab Pegol (Cimzia®), Eculizumab (Soliris®), Natalizumab (Tysabri®)
11. Muromonab-CD3 (Orthoclone OKT®3)
12. Adalimumab (Humira®)
13. Golimumab (Simponi®)1
14. Alemtuzumab (Lemtrada, MabCampath)1
15. Ustekinumab (Stelara®1)2
16. Therapeutic Antibodies - from Past to Future
17. Development trends for new cancer therapeutics and vaccines
18. Antibody Engineering & Therapeutics, The Annual Meeting of The Antibody Society: December 8-12, 2013, Huntington Beach, CA
19. Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
20. Anti-infective monoclonal antibodies: perils and promise of development
21. Recombinant protein therapeutics—success rates, market trends and values to 2010
22. Antibodies to watch in 2014
23. Antibody Engineering and Therapeutics Conference: The Annual Meeting of the Antibody Society, December 812, 2013, Huntington Beach, CA
24. Approval of the first biosimilar antibodies in Europe: A major landmark for the biopharmaceutical industry
25. Antibodies to watch in 2013: Mid-year update
26. Clinical Development of Therapeutic Medicines: A Biopharmaceutical Versus Pharmaceutical Product Comparison
27. The Effects of the Prescription Drug User Fee Act and the Food and Drug Administration Modernization Act on the Development and Approval of Therapeutic Medicines
28. IBCʼs 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics International Conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA
29. Trends in US approvals: new biopharmaceuticals and vaccines
30. Which are the antibodies to watch in 2013?
31. Note of appreciation to reviewers
32. 2012-13 Upcoming meetings
33. IBCʼs 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA
34. 2012 Upcoming Meetings
35. 7th Cancer Scientific Forum of the Cancéropôle Lyon Auvergne Rhône-Alpes March 20-21, 2012, Lyon, France
36. Marketing approval of mogamulizumab A triumph for glyco-engineering
37. Marketed therapeutic antibodies compendium
38. 7th Annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland
39. IBCʼs 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5–8, 2011, San Diego, CA
40. mAbsʼs communication networks
41. Note of appreciation to reviewers
42. Which are the antibodies to watch in 2012?
43. World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA
44. Antibodies to watch in 2021
45. 2011 upcoming meetings
46. Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies
47. Bispecific antibodies and ADCs Once and future kings?
48. Next generation and biosimilar monoclonal antibodies: Essential considerations towards regulatory acceptance in Europe February 3-4, 2011, Freiburg, Germany
49. The amazing, multipurpose antibody
50. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.